Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem
BioSpace
Tue, 07/25/23 - 08:43 pm
Immunogen
ImmunoBiochem
cancer
antibody-drug conjugate
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
Lilly to Buy European ADC Player Emergence Therapeutics
BioSpace
Fri, 06/30/23 - 10:20 am
Eli Lilly
M&A
Emergence Therapeutics
antibody-drug conjugate
oncology
FDA Puts Mersana’s Ovarian Cancer Trials on Partial Clinical Hold
BioSpace
Thu, 06/15/23 - 06:58 pm
Mersana Therapeutics
clinical trials
FDA
ovarian cancer upifitamab rilsodotin
antibody-drug conjugate
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sun, 06/4/23 - 04:31 pm
ASCO 2023 - Seagen
Bristol Myers Squibb
Adcetris
Opdivo
antibody-drug conjugate
Hodgkin's lymphoma
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thu, 05/25/23 - 08:51 pm
ASCO 2023
antibody-drug conjugate
Merck
BioNTech
Daiichi Sankyo
Byondis' breast cancer drug fails to bloom as FDA denies approval
Fierce Biotech
Tue, 05/16/23 - 10:27 pm
Byondis
antibody-drug conjugate
FDA
breast cancer
HER-2 positive breast cancer
Astellas, Sony Team on Novel ADC Platform for Oncology
BioSpace
Tue, 05/16/23 - 12:20 pm
Astellas
Sony Corporation
antibody-drug conjugate
oncology
AstraZeneca Expands ADC Portfolio with $600M Deal with LaNova
BioSpace
Mon, 05/15/23 - 06:35 pm
AstraZeneca
antibody-drug conjugate
LaNova Medicines
Eisai Pays up to $2B for ADC Bearing Its Halaven as Payload
BioSpace
Tue, 05/9/23 - 11:07 am
Eisai
Bliss Biopharmaceutical
clinical trials
antibody-drug conjugate
Halaven
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
BMS signs ADC development deal with Munich-based biotech worth more than $1B
Medical Marketing and Media
Thu, 04/20/23 - 12:00 pm
Bristol Myers Squibb
Tubulius
cancer
solid tumors
antibody-drug conjugate
Takeda taps Innate for a new celiac approach
EP Vantage
Thu, 04/13/23 - 09:58 am
Takeda
celiac disease
Innate Pharma
antibody-drug conjugate
BioNTech Adds Two ADCs in Second Deal in as Many Months
BioSpace
Mon, 04/3/23 - 10:44 pm
BioNTech
antibody-drug conjugate
solid tumors
Duality Biologics
Takeda opens 4th front in assault on celiac, tapping Innate to develop antibody-drug conjugates
Fierce Biotech
Mon, 04/3/23 - 09:44 am
Takeda
celiac disease
antibody-drug conjugate
Innate Pharma
AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
Fierce Biotech
Tue, 03/28/23 - 10:22 am
AbbVie
CytomX Therapeutics
cancer
oncology
antibody-drug conjugate
FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mon, 03/13/23 - 10:54 am
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Wed, 03/1/23 - 09:56 am
Vertex Pharmaceuticals
Immunogen
gen editing
antibody-drug conjugate
exa-cel
AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
Medical Marketing and Media
Fri, 02/24/23 - 09:16 am
AstraZeneca
CMG901
antibody-drug conjugate
gastric cancer
KYM Biosciences
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
Thu, 02/23/23 - 10:00 am
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »